Department of Pathology, The First Affiliated Hospital of University of South China, Hengyang, China.
Department of Anorectal Surgery, The First Affiliated Hospital of University of South China, Hengyang, China.
Cancer Med. 2021 Jun;10(12):3919-3927. doi: 10.1002/cam4.3949. Epub 2021 May 7.
Core needle biopsy (CNB) has become the most common tissue sampling modality for pathological diagnosis of peripheral lung nodules. However, approximately 10% of pulmonary CNB specimens cannot be unambiguously diagnosed, even with auxiliary techniques. This retrospective study investigated the diagnostic value of liquid-based cytology on residual pulmonary CNB material collected from needle rinses.
Computed tomography-guided pulmonary CNB specimens and relevant cytology of CNB needle rinses (CNR) from July 2017 to June 2020 were reviewed. A total of 406 patients, each of whom underwent a CNB procedure, were included in the study.
Of the 406 cases, a more serious diagnosis was rendered by CNR in 6.4% (n = 26) of cases. Furthermore, among these 26 cases, 13 malignancies were confirmed only from CNR. Of the remaining 13 patients with uncertain lesions identified from CNR, six were diagnosed with definite benign lesions from tissue samples, five were found to harbor malignant neoplasms through repeated CNB or follow-up examination, and two had tuberculosis. The sensitivity (320/332, 96.4%) of combined CNR/CNB (both CNR and CNB) in distinguishing malignancies from benign lesions was higher than that of CNB alone (307/332, 92.5%). A total of 320 malignant neoplasms included 198 cases of primary lung adenocarcinoma and 71 cases of primary lung squamous cell carcinoma.
CNR with higher nuclear and cytoplasmic resolution than CNB exhibited a high diagnostic efficacy for differentiating malignant from benign lesions in the lung. Moreover, combined CNR/CNB achieved optimal results in reducing the false-negative rate and the subtyping of non-small cell lung cancer.
经皮肺穿刺活检(CNB)已成为肺部周围性结节病理诊断最常用的组织取样方法。然而,即使使用辅助技术,仍有约 10%的肺部 CNB 标本无法明确诊断。本回顾性研究调查了液体基细胞学对从 CNB 针冲洗中收集的残留肺 CNB 材料的诊断价值。
回顾性分析 2017 年 7 月至 2020 年 6 月期间接受 CT 引导下肺 CNB 及相关 CNB 针冲洗液(CNR)细胞学检查的患者资料。共纳入 406 例接受 CNB 检查的患者。
406 例患者中,26 例(6.4%)的 CNR 做出了更严重的诊断。这 26 例中,13 例恶性肿瘤仅从 CNR 中得到证实。在其余 13 例从 CNR 中发现不确定病变的患者中,6 例从组织样本中诊断为明确良性病变,5 例通过重复 CNB 或随访检查发现恶性肿瘤,2 例为肺结核。CNR/CNB(CNR 和 CNB 均有)联合诊断恶性与良性病变的敏感度(320/332,96.4%)高于 CNB 单独检查(307/332,92.5%)。320 例恶性肿瘤中,原发性肺腺癌 198 例,原发性肺鳞癌 71 例。
CNR 比 CNB 具有更高的核和细胞质分辨率,对区分肺部良恶性病变具有较高的诊断效能。此外,联合 CNR/CNB 可降低假阴性率,对非小细胞肺癌进行亚型分类。